These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

452 related articles for article (PubMed ID: 28528705)

  • 1. Complications of Proton Pump Inhibitor Therapy.
    Vaezi MF; Yang YX; Howden CW
    Gastroenterology; 2017 Jul; 153(1):35-48. PubMed ID: 28528705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of community-acquired pneumonia in veteran patients to whom proton pump inhibitors were dispensed.
    Hermos JA; Young MM; Fonda JR; Gagnon DR; Fiore LD; Lawler EV
    Clin Infect Dis; 2012 Jan; 54(1):33-42. PubMed ID: 22100573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Community acquired pneumonia incidence before and after proton pump inhibitor prescription: population based study.
    Othman F; Crooks CJ; Card TR
    BMJ; 2016 Nov; 355():i5813. PubMed ID: 28715344
    [No Abstract]   [Full Text] [Related]  

  • 4. Proton-pump inhibitors and chronic kidney disease: Hidden consequences of an inappropriate drug use?
    Schiffl H; Al-Nemnem E; Lang SM
    Saudi J Kidney Dis Transpl; 2020; 31(2):312-319. PubMed ID: 32394903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recurrent community-acquired pneumonia in patients starting acid-suppressing drugs.
    Eurich DT; Sadowski CA; Simpson SH; Marrie TJ; Majumdar SR
    Am J Med; 2010 Jan; 123(1):47-53. PubMed ID: 20102991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adverse Event Reporting for Proton Pump Inhibitor Therapy: An Overview of Systematic Reviews.
    Abramowitz J; Thakkar P; Isa A; Truong A; Park C; Rosenfeld RM
    Otolaryngol Head Neck Surg; 2016 Oct; 155(4):547-54. PubMed ID: 27188706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Risks and Benefits of Long-term Use of Proton Pump Inhibitors: Expert Review and Best Practice Advice From the American Gastroenterological Association.
    Freedberg DE; Kim LS; Yang YX
    Gastroenterology; 2017 Mar; 152(4):706-715. PubMed ID: 28257716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Results of an intervention in an academic Internal Medicine Clinic to continue, step-down, or discontinue proton pump inhibitor therapy related to a tennessee medicaid formulary change.
    Ramser KL; Sprabery LR; Hamann GL; George CM; Will A
    J Manag Care Pharm; 2009 May; 15(4):344-50. PubMed ID: 19422274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are proton pump inhibitors associated with the development of community-acquired pneumonia? A meta-analysis.
    Giuliano C; Wilhelm SM; Kale-Pradhan PB
    Expert Rev Clin Pharmacol; 2012 May; 5(3):337-44. PubMed ID: 22697595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Latest insights into the hot question of proton pump inhibitor safety - a narrative review.
    Savarino V; Marabotto E; Furnari M; Zingone F; Zentilin P; Savarino E
    Dig Liver Dis; 2020 Aug; 52(8):842-852. PubMed ID: 32513631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proton pump inhibitor therapy predisposes to community-acquired Streptococcus pneumoniae pneumonia.
    de Jager CP; Wever PC; Gemen EF; van Oijen MG; van Gageldonk-Lafeber AB; Siersema PD; Kusters GC; Laheij RJ
    Aliment Pharmacol Ther; 2012 Nov; 36(10):941-9. PubMed ID: 23034135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The risks of PPI therapy.
    Moayyedi P; Leontiadis GI
    Nat Rev Gastroenterol Hepatol; 2012 Feb; 9(3):132-9. PubMed ID: 22330810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meta-analysis of proton pump inhibitors induced risk of community-acquired pneumonia.
    Nguyen PA; Islam M; Galvin CJ; Chang CC; An SY; Yang HC; Huang CW; Li YJ; Iqbal U
    Int J Qual Health Care; 2020 Jun; 32(5):292-299. PubMed ID: 32436582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are proton pump inhibitors really so dangerous?
    Savarino V; Dulbecco P; Savarino E
    Dig Liver Dis; 2016 Aug; 48(8):851-9. PubMed ID: 27321544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adverse outcomes of long-term use of proton pump inhibitors: a systematic review and meta-analysis.
    Islam MM; Poly TN; Walther BA; Dubey NK; Anggraini Ningrum DN; Shabbir SA; Jack Li YC
    Eur J Gastroenterol Hepatol; 2018 Dec; 30(12):1395-1405. PubMed ID: 30028775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proton-pump inhibitors adverse effects: a review of the evidence and position statement by the Sociedad Española de Patología Digestiva.
    de la Coba Ortiz C; Argüelles Arias F; Martín de Argila de Prados C; Júdez Gutiérrez J; Linares Rodríguez A; Ortega Alonso A; Rodríguez de Santiago E; Rodríguez-Téllez M; Vera Mendoza MI; Aguilera Castro L; Álvarez Sánchez Á; Andrade Bellido RJ; Bao Pérez F; Castro Fernández M; Giganto Tomé F
    Rev Esp Enferm Dig; 2016 Apr; 108(4):207-24. PubMed ID: 27034082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of proton pump inhibitors with lack of diagnostic indications in 22 Midwestern US skilled nursing facilities.
    Patterson Burdsall D; Flores HC; Krueger J; Garretson S; Gorbien MJ; Iacch A; Dobbs V; Homa T
    J Am Med Dir Assoc; 2013 Jun; 14(6):429-32. PubMed ID: 23583000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proton Pump Inhibitors and the Risk of Community-Acquired Pneumonia: An Updated Meta-analysis.
    Xun X; Yin Q; Fu Y; He X; Dong Z
    Ann Pharmacother; 2022 May; 56(5):524-532. PubMed ID: 34425689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discontinuing Long-Term PPI Therapy: Why, With Whom, and How?
    Targownik L
    Am J Gastroenterol; 2018 Apr; 113(4):519-528. PubMed ID: 29557943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review of proton pump inhibitors for the initial treatment of heartburn: is there a dose ceiling effect?
    Kushner PR; Peura DA
    Adv Ther; 2011 May; 28(5):367-88. PubMed ID: 21484335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.